An investigation on behalf of investors of Kezar Life Sciences, Inc. (NASDAQ: KZR) shares over potential securities laws violations by Kezar Life Sciences, Inc. and certain of its directors and officers in connection with certain financial statements was announced.
Investors who purchased shares of Kezar Life Sciences, Inc. (NASDAQ: KZR), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Kezar Life Sciences, Inc. (NASDAQ: KZR) concerning whether a series of statements by Kezar Life Sciences, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Francisco, CA based Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of small molecule therapeutics to treat unmet needs in autoimmunity and cancer in the United States. Kezar Life Sciences, Inc. went public in June 2018 and sold 5 million shares at $15 per share.
Since then, shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) declined to as low as $5.65 per share on July 18, 2019.
Those who purchased shares of Kezar Life Sciences, Inc. (NASDAQ: KZR) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.